世界のT細胞表面糖タンパク質CD3イプシロン鎖市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6030
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、T細胞表面糖タンパク質CD3イプシロン鎖の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ND-007、フォラルマブ、コルテリズマブ、AVA-002、その他）、用途別市場規模（自己免疫疾患、B型肝炎、多発性硬化症、前立腺がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・T細胞表面糖タンパク質CD3イプシロン鎖の市場動向
・企業の競争状況、市場シェア
・T細胞表面糖タンパク質CD3イプシロン鎖の種類別市場規模と予測2016-2027（ND-007、フォラルマブ、コルテリズマブ、AVA-002、その他）
・T細胞表面糖タンパク質CD3イプシロン鎖の用途別市場規模と予測2016-2027（自己免疫疾患、B型肝炎、多発性硬化症、前立腺がん、その他）
・T細胞表面糖タンパク質CD3イプシロン鎖の北米市場規模2016-2027（アメリカ、カナダ）
・T細胞表面糖タンパク質CD3イプシロン鎖の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・T細胞表面糖タンパク質CD3イプシロン鎖のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・T細胞表面糖タンパク質CD3イプシロン鎖の中南米市場規模2016-2027（メキシコ、ブラジル）
・T細胞表面糖タンパク質CD3イプシロン鎖の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen Inc、Celgene Corp、F. Hoffmann-La Roche Ltd、GlaxoSmithKline Plc、MacroGenics Inc、Meridigen Biotech Co Ltd、Numab Innovation AG、SYNIMMUNE GmbH、Tiziana Life Sciences Plc）
・結論

Market Analysis and Insights: Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market
The global T Cell Surface Glycoprotein CD3 Epsilon Chain market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global T Cell Surface Glycoprotein CD3 Epsilon Chain market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global T Cell Surface Glycoprotein CD3 Epsilon Chain market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global T Cell Surface Glycoprotein CD3 Epsilon Chain market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global T Cell Surface Glycoprotein CD3 Epsilon Chain market.

Global T Cell Surface Glycoprotein CD3 Epsilon Chain Scope and Market Size
T Cell Surface Glycoprotein CD3 Epsilon Chain market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T Cell Surface Glycoprotein CD3 Epsilon Chain market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
ND-007
Foralumab
Coltelizumab
AVA-002
Others

Segment by Application
Autoimmune Disorders
Hepatitis B
Multiple Sclerosis
Prostate Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen Inc
Celgene Corp
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
MacroGenics Inc
Meridigen Biotech Co Ltd
Numab Innovation AG
SYNIMMUNE GmbH
Tiziana Life Sciences Plc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ND-007
1.2.3 Foralumab
1.2.4 Coltelizumab
1.2.5 AVA-002
1.2.6 Others
1.3 Market by Application
1.3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Autoimmune Disorders
1.3.3 Hepatitis B
1.3.4 Multiple Sclerosis
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Perspective (2016-2027)
2.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Growth Trends by Regions
2.2.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Historic Market Share by Regions (2016-2021)
2.2.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Regions (2022-2027)
2.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Industry Dynamic
2.3.1 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Trends
2.3.2 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Drivers
2.3.3 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Challenges
2.3.4 T Cell Surface Glycoprotein CD3 Epsilon Chain Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top T Cell Surface Glycoprotein CD3 Epsilon Chain Players by Revenue
3.1.1 Global Top T Cell Surface Glycoprotein CD3 Epsilon Chain Players by Revenue (2016-2021)
3.1.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Players (2016-2021)
3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue
3.4 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Concentration Ratio
3.4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in 2020
3.5 T Cell Surface Glycoprotein CD3 Epsilon Chain Key Players Head office and Area Served
3.6 Key Players T Cell Surface Glycoprotein CD3 Epsilon Chain Product Solution and Service
3.7 Date of Enter into T Cell Surface Glycoprotein CD3 Epsilon Chain Market
3.8 Mergers & Acquisitions, Expansion Plans

4 T Cell Surface Glycoprotein CD3 Epsilon Chain Breakdown Data by Type
4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Historic Market Size by Type (2016-2021)
4.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Type (2022-2027)

5 T Cell Surface Glycoprotein CD3 Epsilon Chain Breakdown Data by Application
5.1 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Historic Market Size by Application (2016-2021)
5.2 Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2016-2027)
6.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type
6.2.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021)
6.2.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2022-2027)
6.2.3 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2027)
6.3 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application
6.3.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2021)
6.3.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2022-2027)
6.3.3 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2027)
6.4 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country
6.4.1 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2016-2021)
6.4.2 North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2016-2027)
7.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type
7.2.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021)
7.2.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2022-2027)
7.2.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2027)
7.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application
7.3.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2021)
7.3.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2022-2027)
7.3.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2027)
7.4 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country
7.4.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2016-2021)
7.4.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2016-2027)
8.2 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type
8.2.1 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021)
8.2.2 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2022-2027)
8.2.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2027)
8.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application
8.3.1 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2021)
8.3.2 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2022-2027)
8.3.3 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2027)
8.4 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region
8.4.1 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2016-2021)
8.4.2 Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2016-2027)
9.2 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type
9.2.1 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021)
9.2.2 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2022-2027)
9.2.3 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2027)
9.3 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application
9.3.1 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2021)
9.3.2 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2022-2027)
9.3.3 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2027)
9.4 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country
9.4.1 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2016-2021)
9.4.2 Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (2016-2027)
10.2 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type
10.2.1 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021)
10.2.2 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2022-2027)
10.2.3 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2027)
10.3 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application
10.3.1 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2021)
10.3.2 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2022-2027)
10.3.3 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2027)
10.4 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country
10.4.1 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2016-2021)
10.4.2 Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Introduction
11.1.4 Amgen Inc Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
11.1.5 Amgen Inc Recent Development
11.2 Celgene Corp
11.2.1 Celgene Corp Company Details
11.2.2 Celgene Corp Business Overview
11.2.3 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Introduction
11.2.4 Celgene Corp Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
11.2.5 Celgene Corp Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Company Details
11.4.2 GlaxoSmithKline Plc Business Overview
11.4.3 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Introduction
11.4.4 GlaxoSmithKline Plc Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
11.4.5 GlaxoSmithKline Plc Recent Development
11.5 MacroGenics Inc
11.5.1 MacroGenics Inc Company Details
11.5.2 MacroGenics Inc Business Overview
11.5.3 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Introduction
11.5.4 MacroGenics Inc Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
11.5.5 MacroGenics Inc Recent Development
11.6 Meridigen Biotech Co Ltd
11.6.1 Meridigen Biotech Co Ltd Company Details
11.6.2 Meridigen Biotech Co Ltd Business Overview
11.6.3 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Introduction
11.6.4 Meridigen Biotech Co Ltd Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
11.6.5 Meridigen Biotech Co Ltd Recent Development
11.7 Numab Innovation AG
11.7.1 Numab Innovation AG Company Details
11.7.2 Numab Innovation AG Business Overview
11.7.3 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Introduction
11.7.4 Numab Innovation AG Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
11.7.5 Numab Innovation AG Recent Development
11.8 SYNIMMUNE GmbH
11.8.1 SYNIMMUNE GmbH Company Details
11.8.2 SYNIMMUNE GmbH Business Overview
11.8.3 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Chain Introduction
11.8.4 SYNIMMUNE GmbH Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
11.8.5 SYNIMMUNE GmbH Recent Development
11.9 Tiziana Life Sciences Plc
11.9.1 Tiziana Life Sciences Plc Company Details
11.9.2 Tiziana Life Sciences Plc Business Overview
11.9.3 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Introduction
11.9.4 Tiziana Life Sciences Plc Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
11.9.5 Tiziana Life Sciences Plc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ND-007
Table 3. Key Players of Foralumab
Table 4. Key Players of Coltelizumab
Table 5. Key Players of AVA-002
Table 6. Key Players of Others
Table 7. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Regions (2016-2021)
Table 11. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Regions (2022-2027)
Table 13. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Trends
Table 14. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Drivers
Table 15. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Challenges
Table 16. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Restraints
Table 17. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Players (2016-2021)
Table 19. Global Top T Cell Surface Glycoprotein CD3 Epsilon Chain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain as of 2020)
Table 20. Ranking of Global Top T Cell Surface Glycoprotein CD3 Epsilon Chain Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players T Cell Surface Glycoprotein CD3 Epsilon Chain Product Solution and Service
Table 24. Date of Enter into T Cell Surface Glycoprotein CD3 Epsilon Chain Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021) (US$ Million)
Table 27. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2016-2021)
Table 28. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2016-2021)
Table 32. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021) (US$ Million)
Table 35. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2021) (US$ Million)
Table 37. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Inc Company Details
Table 65. Amgen Inc Business Overview
Table 66. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product
Table 67. Amgen Inc Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021) & (US$ Million)
Table 68. Amgen Inc Recent Development
Table 69. Celgene Corp Company Details
Table 70. Celgene Corp Business Overview
Table 71. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Chain Product
Table 72. Celgene Corp Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021) & (US$ Million)
Table 73. Celgene Corp Recent Development
Table 74. F. Hoffmann-La Roche Ltd Company Details
Table 75. F. Hoffmann-La Roche Ltd Business Overview
Table 76. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product
Table 77. F. Hoffmann-La Roche Ltd Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021) & (US$ Million)
Table 78. F. Hoffmann-La Roche Ltd Recent Development
Table 79. GlaxoSmithKline Plc Company Details
Table 80. GlaxoSmithKline Plc Business Overview
Table 81. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product
Table 82. GlaxoSmithKline Plc Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021) & (US$ Million)
Table 83. GlaxoSmithKline Plc Recent Development
Table 84. MacroGenics Inc Company Details
Table 85. MacroGenics Inc Business Overview
Table 86. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Chain Product
Table 87. MacroGenics Inc Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021) & (US$ Million)
Table 88. MacroGenics Inc Recent Development
Table 89. Meridigen Biotech Co Ltd Company Details
Table 90. Meridigen Biotech Co Ltd Business Overview
Table 91. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Chain Product
Table 92. Meridigen Biotech Co Ltd Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021) & (US$ Million)
Table 93. Meridigen Biotech Co Ltd Recent Development
Table 94. Numab Innovation AG Company Details
Table 95. Numab Innovation AG Business Overview
Table 96. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Chain Product
Table 97. Numab Innovation AG Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021) & (US$ Million)
Table 98. Numab Innovation AG Recent Development
Table 99. SYNIMMUNE GmbH Company Details
Table 100. SYNIMMUNE GmbH Business Overview
Table 101. SYNIMMUNE GmbH Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021) & (US$ Million)
Table 102. SYNIMMUNE GmbH Recent Development
Table 103. Tiziana Life Sciences Plc Company Details
Table 104. Tiziana Life Sciences Plc Business Overview
Table 105. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Chain Product
Table 106. Tiziana Life Sciences Plc Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021) & (US$ Million)
Table 107. Tiziana Life Sciences Plc Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type: 2020 VS 2027
Figure 2. ND-007 Features
Figure 3. Foralumab Features
Figure 4. Coltelizumab Features
Figure 5. AVA-002 Features
Figure 6. Others Features
Figure 7. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application: 2020 VS 2027
Figure 8. Autoimmune Disorders Case Studies
Figure 9. Hepatitis B Case Studies
Figure 10. Multiple Sclerosis Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. T Cell Surface Glycoprotein CD3 Epsilon Chain Report Years Considered
Figure 14. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Regions: 2020 VS 2027
Figure 17. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Regions (2022-2027)
Figure 18. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Players in 2020
Figure 19. Global Top T Cell Surface Glycoprotein CD3 Epsilon Chain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Cell Surface Glycoprotein CD3 Epsilon Chain as of 2020
Figure 20. The Top 10 and 5 Players Market Share by T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue in 2020
Figure 21. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2016-2021)
Figure 22. Global T Cell Surface Glycoprotein CD3 Epsilon Chain Revenue Market Share by Type (2022-2027)
Figure 23. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type (2016-2027)
Figure 25. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application (2016-2027)
Figure 26. North America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Country (2016-2027)
Figure 27. United States T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type (2016-2027)
Figure 31. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application (2016-2027)
Figure 32. Europe T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Country (2016-2027)
Figure 33. Germany T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type (2016-2027)
Figure 41. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application (2016-2027)
Figure 42. Asia-Pacific T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Region (2016-2027)
Figure 43. China T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type (2016-2027)
Figure 51. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application (2016-2027)
Figure 52. Latin America T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Country (2016-2027)
Figure 53. Mexico T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Type (2016-2027)
Figure 57. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Application (2016-2027)
Figure 58. Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Chain Market Share by Country (2016-2027)
Figure 59. Turkey T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE T Cell Surface Glycoprotein CD3 Epsilon Chain Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Amgen Inc Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
Figure 63. Celgene Corp Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
Figure 64. F. Hoffmann-La Roche Ltd Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
Figure 65. GlaxoSmithKline Plc Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
Figure 66. MacroGenics Inc Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
Figure 67. Meridigen Biotech Co Ltd Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
Figure 68. Numab Innovation AG Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
Figure 69. SYNIMMUNE GmbH Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
Figure 70. Tiziana Life Sciences Plc Revenue Growth Rate in T Cell Surface Glycoprotein CD3 Epsilon Chain Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の糖タンパク質分析市場規模・現状・予測（2021年-2027年）

Global Glycoprotein Analysis Market Size, Status and Forecast 2021-2027
QFJ1-4267 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、糖タンパク質分析の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分子試薬技術、質量分析技術）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のプロテインキナーゼCイプシロン型市場規模・現状・予測（2021年-2027年）

Global Protein Kinase C Epsilon Type Market Size, Status and Forecast 2021-2027
QFJ1-5970 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、プロテインキナーゼCイプシロン型の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブリオスタチン-1、DHACP-6、VMD-1201、その他）、用途別市場規模（アルコール依存症、頭頸部がん、虚血性脳卒...

T細胞特異的表面糖タンパク質CD28のグローバル市場調査 2019年

Global T Cell Specific Surface Glycoprotein CD28 Market Professional Survey Report 2019
QYR9NV13067 2019年11月16日 105Pages
※本調査レポートは、T細胞特異的表面糖タンパク質CD28の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、FPT-155、FR-104、ルリズマブペゴル、その他...

T細胞特異的表面糖タンパク質CD28のグローバル市場調査 2019年

T細胞表面糖タンパク質CD4のグローバル市場調査 2019年

Global T Cell Surface Glycoprotein CD4 Market Professional Survey Report 2019
QYR9NV13068 2019年11月16日 109Pages
※本調査レポートは、T細胞表面糖タンパク質CD4の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他に、...

T細胞表面糖タンパク質CD4のグローバル市場調査 2019年

世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年）

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5611 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の不死化細胞株市場規模・現状・予測（2021年-2027年）

Global Immortalized Cell Line Market Size, Status and Forecast 2021-2027
QFJ1-4347 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、不死化細胞株の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（幹細胞治療、細胞移植、薬物輸送、その他）、用途別市場規模（製薬＆バイオ医薬品企業、受託研究機関、研究所）、主要地域別市場規模（北米、アメリカ...

世界の自己細胞療法市場規模・現状・予測（2021年-2027年）

Global Autologous Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3873 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、自己細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（骨髄、表皮）、用途別市場規模（神経内科、整形外科、がん、創傷治癒、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のB細胞リンパ腫2阻害剤市場規模・現状・予測（2021年-2027年）

Global B-cell lymphoma 2 Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5610 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、B細胞リンパ腫2阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病）、主要地域別市場規模（北米、アメ...

T細胞特異的表面糖タンパク質CD28のグローバル市場調査 2019年 The global T Cell Specific Surface Glycoprotein CD28 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T Cell Specific Surface Glycoprotein CD28 volume and value at global level, regional level and co…
T細胞特異的表面糖タンパク質CD28のグローバル市場調査 2019年 The global T Cell Specific Surface Glycoprotein CD28 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T Cell Specific Surface Glycoprotein CD28 volume and value at global level, regional level and co…
T細胞表面糖タンパク質CD4のグローバル市場調査 2019年 The global T Cell Surface Glycoprotein CD4 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T Cell Surface Glycoprotein CD4 volume and value at global level, regional level and company level. From a …
T細胞表面糖タンパク質CD4のグローバル市場調査 2019年 The global T Cell Surface Glycoprotein CD4 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T Cell Surface Glycoprotein CD4 volume and value at global level, regional level and company level. From a …
世界の糖タンパク質分析市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Glycoprotein Analysis Market The global Glycoprotein Analysis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…